SLC30A8 and type 2 diabetes mellitus: Such an approach should integrate systematic assessment of zinc status, Cu/Zn ratio, and relevant gene–nutrient interactions (e.g., SLC30A8 polymorphisms) into clinical decision-making for T2DM management.